Komipharm International Co. Ltd (041960) — Cash Flow Reinvestment Rate
Komipharm International Co. Ltd (041960) has a Cash Flow Reinvestment Rate of 5.10x as of December 2025, reinvesting ₩4.83 Billion (capex ₩1.85 Billion plus investments ₩2.98 Billion) from operating cash flow of ₩946.94 Million. See Komipharm International Co. Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Komipharm International Co. Ltd Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Komipharm International Co. Ltd across 6 annual periods. For the full cash flow conversion analysis, see Komipharm International Co. Ltd cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Komipharm International Co. Ltd (2013–2024)
Year-by-year capital reinvestment analysis for Komipharm International Co. Ltd. See financial flexibility index of Komipharm International Co. Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.67x | ₩5.96 Billion | ₩8.85 Billion | ₩3.98 Billion | ▼ -99.1% |
| 2020 | 76.26x | ₩1.92 Billion | ₩25.20 Million | ₩1.66 Billion | ▲ +1149.9% |
| 2019 | 6.10x | ₩5.80 Billion | ₩950.79 Million | ₩5.74 Billion | ▼ -57.5% |
| 2017 | 14.35x | ₩3.38 Billion | ₩235.64 Million | ₩2.68 Billion | ▲ +5.5% |
| 2016 | 13.60x | ₩16.43 Billion | ₩1.21 Billion | ₩12.24 Billion | ▲ +114.6% |
| 2013 | 6.34x | ₩24.93 Billion | ₩3.93 Billion | ₩24.93 Billion | — |